Work

Safety and Efficacy of Linvoseltamab (LINVO) in Patients (Pts) with High-risk Smoldering Multiple Myeloma (HR-SMM): First Results from the Phase 2 LINKER-SMM1 Trial

Year: 2025

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(25)04011-x

Authors: Paula Rodríguez-Otero, Juan José Bargay Lleonart, Maria Esther Clavero, Paz Ribas, Maria del Carmen Martínez-Chamorro, Anna Maria Sureda, Albert Oriol, Maria Jose Moreno, Maria Esther Gonzalez, Laura Rosiñol, Diego Conde Royo, Bruno Paiva, Jacob Glass, Yoon Jin, Anju Shrestha, Arijit Sinha, Anita Boyapati, Anasuya Hazra, Glenn Kroog, Shawn Sarkaria, Jesús San-Miguel, María-Victoria Mateos

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414303142

FWCI: 5.874

Cites:

Cited by: 8

Related to: 10